Chargement de la fiche…
Chargement de la fiche…
rhumatologie
Hospitalo-universitaire
Castelnaudary (11400)
Rheumatoid Arthritis Research and Therapies · Spondyloarthritis Studies and Treatments · Systemic Lupus Erythematosus Research
Côté patient
Choisissez votre pathologie pour une explication en langage simple.
Parcourir toutes les pathologies →Des applications évaluées par MonRhumato, sélectionnées pour les patients.
MapathoPlateforme communautaire maladies chroniques + annuaire pair-validé
GustaveAgent IA souverain pour information patient sourcée
Remedee LabsBracelet stimulateur d'endorphines pour douleur chroniqueTout est calculé à partir des sources publiques (RPPS, PubMed, OpenAlex, OpenStreetMap…) — aucun classement éditorial.
2005–2025
Université Toulouse III - Paul Sabatier
2025
Inserm
2025
Université Fédérale de Toulouse Midi-Pyrénées
2021–2022
Université Fédérale de Toulouse Midi-Pyrénées
2018–2021
Centre National de la Recherche Scientifique
2012–2021
Inserm
0
h-index
0
i10
0
citations
Le h-index mesure la productivité scientifique : ce médecin a publié 54 articles cités au moins 54fois par d'autres chercheurs. Plus c'est élevé, plus son travail influence la communauté médicale.
Rhumatologie (SM) — Diplôme d'Études Spécialisées
DE Docteur en médecine — Capacité / Certificat d'Études Spéciales
0
travaux
0
h-index
0
i10-index
0
citations
2025Diagnostics (Basel, Switzerland)
PubMed ↗Predicting Clinical Response to Monoclonal TNF Inhibitors in Rheumatoid Arthritis: A Transcriptomic Approach Based on Transmembrane TNF Reverse Signaling and Nrf2 Activation
2025International journal of molecular sciences
PubMed ↗Evidence for Pro-Inflammatory Activity of LTα3 on Macrophages: Significance for Experimental Arthritis and for Therapeutic Switching in Rheumatoid Arthritis Patients
2022Nutrients
PubMed ↗Serum Fatty Acid Profiles Are Associated with Disease Activity in Early Rheumatoid Arthritis: Results from the ESPOIR Cohort
2022La Revue du praticien
PubMed ↗[JAK inhibitors in rheumatology]
2021JAMA network open
PubMed ↗Association Between Tumor Necrosis Factor Inhibitors and the Risk of Hospitalization or Death Among Patients With Immune-Mediated Inflammatory Disease and COVID-19
2021Rheumatology (Oxford, England)
PubMed ↗Current favourable 10-year outcome of patients with early rheumatoid arthritis: data from the ESPOIR cohort
2021iScience
PubMed ↗Evidence for tmTNF reverse signaling in vivo: Implications for an arginase-1-mediated therapeutic effect of TNF inhibitors during inflammation
2021Bulletin du cancer
PubMed ↗[Management of toxicities of BRAF inhibitors and MEK inhibitors in advanced melanoma]
2021Revue du rhumatisme (Ed. francaise : 1993)
PubMed ↗Prise en charge des patients atteints de maladies rhumatismales pendant la pandémie de COVID-19 : la Société française de rhumatologie répond aux questions fréquentes posées jusqu’en mai 2020
2021Arthritis research & therapy
PubMed ↗Cytomegalovirus infection: friend or foe in rheumatoid arthritis?
2020Journal of bone and mineral research : the official journal of the American Society for Bone and Mineral Research
PubMed ↗Inhibition of Osteoclastogenesis by the RNA-Binding Protein QKI5: a Novel Approach to Protect from Bone Resorption
2020Joint bone spine
PubMed ↗Managing patients with rheumatic diseases during the COVID-19 pandemic: The French Society of Rheumatology answers to most frequently asked questions up to May 2020
2020RMD open
PubMed ↗Part of pain labelled neuropathic in rheumatic disease might be rather nociplastic
2020The Journal of rheumatology
PubMed ↗Outcomes and Findings of the International Rheumatoid Arthritis (RA) BIODAM Cohort for Validation of Soluble Biomarkers in RA
2020Journal of the European Academy of Dermatology and Venereology : JEADV
PubMed ↗Early-onset granulomatous arthritis, uveitis and skin rash: characterization of skin involvement in Blau syndrome
2020Arthritis research & therapy
PubMed ↗Reduced progression of bone erosion in cytomegalovirus seropositive rheumatoid arthritis patients
2019Frontiers in immunology
PubMed ↗Rheumatoid Synovial Fluids Regulate the Immunomodulatory Potential of Adipose-Derived Mesenchymal Stem Cells Through a TNF/NF-κB-Dependent Mechanism
2019Frontiers in immunology
PubMed ↗Corrigendum: Rheumatoid Synovial Fluids Regulate the Immunomodulatory Potential of Adipose-Derived Mesenchymal Stem Cells Through a TNF/NF-κB-Dependent Mechanism
2019Arthritis research & therapy
PubMed ↗Predictors of good response to conventional synthetic DMARDs in early seronegative rheumatoid arthritis: data from the ESPOIR cohort
2019Seminars in arthritis and rheumatism
PubMed ↗Characteristics and clinical outcomes after treatment of a national cohort of PCR-positive Lyme arthritis
2019Joint bone spine
PubMed ↗Update of French society for rheumatology recommendations for managing rheumatoid arthritis
2019Arthritis research & therapy
PubMed ↗Association between IL23R and ERAP1 polymorphisms and sacroiliac or spinal MRI inflammation in spondyloarthritis: DESIR cohort data
2018Journal of the European Academy of Dermatology and Venereology : JEADV
PubMed ↗Psoriatic arthritis screening by the dermatologist: development and first validation of the 'PURE-4 scale'
2017Joint bone spine
PubMed ↗Infectious risk associated to orthopaedic surgery for rheumatoid arthritis patients treated by anti-TNFalpha
2019Joint bone spine
PubMed ↗Two-year abatacept retention rate in clinical practice in the French ACTION cohort
2019The pharmacogenomics journal
PubMed ↗A single nucleotide polymorphism of IL6-receptor is associated with response to tocilizumab in rheumatoid arthritis patients
2018Rheumatology (Oxford, England)
PubMed ↗Serious infusion-related reaction after rituximab, abatacept and tocilizumab in rheumatoid arthritis: prospective registry data
2017RMD open
PubMed ↗Impact of gender on the response and tolerance to abatacept in patients with rheumatoid arthritis: results from the 'ORA' registry
2017Rheumatology (Oxford, England)
PubMed ↗A rare case of rheumatoid pachyleptomeningitis successfully treated with rituximab
2017Joint bone spine
PubMed ↗The effect of body mass index on clinical response to abatacept as a first-line biologic for rheumatoid arthritis: 6-month results from the 2-year, observational, prospective ACTION study
2017RMD open
PubMed ↗Real-world predictors of 12-month intravenous abatacept retention in patients with rheumatoid arthritis in the ACTION observational study
2017Rheumatology (Oxford, England)
PubMed ↗Safety of surgery in patients with rheumatoid arthritis treated by abatacept: data from the French Orencia in Rheumatoid Arthritis Registry
2019RMD open
PubMed ↗Short-term risk of major adverse cardiovascular events or congestive heart failure in patients with psoriatic arthritis or psoriasis initiating a biological therapy: a meta-analysis of randomised controlled trials
2019Joint bone spine
PubMed ↗The effect of periodontal treatment on patients with rheumatoid arthritis: The ESPERA randomised controlled trial
2018Joint bone spine
PubMed ↗An e-health interactive self-assessment website (Sanoia(®)) in rheumatoid arthritis. A 12-month randomized controlled trial in 320 patients
2018Archives of physical medicine and rehabilitation
PubMed ↗Effectiveness of Exercise Programs in Ankylosing Spondylitis: A Meta-Analysis of Randomized Controlled Trials
2019RMD open
PubMed ↗Short-term risk of major adverse cardiovascular events or congestive heart failure in patients with psoriatic arthritis or psoriasis initiating a biological therapy: a meta-analysis of randomised controlled trials
2018Annals of the rheumatic diseases
PubMed ↗Risk of losing remission, low disease activity or radiographic progression in case of bDMARD discontinuation or tapering in rheumatoid arthritis: systematic analysis of the literature and meta-analysis
2018Joint bone spine
PubMed ↗Anti-citrullinated peptides antibodies in systemic sclerosis: Meta-analysis of frequency and meaning
2018Archives of physical medicine and rehabilitation
PubMed ↗Effectiveness of Exercise Programs in Ankylosing Spondylitis: A Meta-Analysis of Randomized Controlled Trials
2025Advances in therapy
PubMed ↗Real-World Effectiveness and Safety of Infliximab Biosimilar CT-P13 for Rheumatic Diseases: A National Observational Cohort Study (ReFLECT)
2022Joint bone spine
PubMed ↗Changes in etanercept and adalimumab biosimilar prescriptions for the initial treatment of rheumatoid arthritis in France: Data from the ART-SFR Registry
2021Clinical and experimental rheumatology
PubMed ↗BENEFIT: real-world effectiveness of SB4 after transition from reference etanercept in rheumatoid arthritis and axial spondyloarthritis
2023Rheumatology (Oxford, England)
PubMed ↗Stricter treat-to-target in RA does not result in less radiographic progression: a longitudinal analysis in RA BIODAM
2020The Journal of rheumatology
PubMed ↗Adherence to Treat-to-target Management in Rheumatoid Arthritis and Associated Factors: Data from the International RA BIODAM Cohort
2020Annals of the rheumatic diseases
PubMed ↗Is treat-to-target really working in rheumatoid arthritis? a longitudinal analysis of a cohort of patients treated in daily practice (RA BIODAM)
2020Clinical and experimental rheumatology
PubMed ↗Biological DMARD efficacy in psoriatic arthritis: a systematic literature review and meta-analysis on articular, enthesitis, dactylitis, skin and functional outcomes
2017RMD open
PubMed ↗Relationships between ultrasound enthesitis, disease activity and axial radiographic structural changes in patients with early spondyloarthritis: data from DESIR cohort
2019Viruses
PubMed ↗Chronic Hepatitis E in Rheumatology and Internal Medicine Patients: A Retrospective Multicenter European Cohort Study
2019European radiology
PubMed ↗Prevalence of inflammatory posterior arch abnormalities on lumbar spine MRI in spondyloarthritis patients compared with low back pain patients
2026Arthritis & rheumatology (Hoboken, N.J.)
PubMed ↗Comparative Efficacy and Safety of Anakinra and Canakinumab in Patients With VEXAS Syndrome: An International Multicenter Study
2018Arthritis research & therapy
PubMed ↗Modulation of T-cell responses by anti-tumor necrosis factor treatments in rheumatoid arthritis: a review
2018Archives of physical medicine and rehabilitation
PubMed ↗Effectiveness of Exercise Programs in Ankylosing Spondylitis: A Meta-Analysis of Randomized Controlled Trials
2025Article
Evidence for Pro-Inflammatory Activity of LTα3 on Macrophages: Significance for Experimental Arthritis and for Therapeutic Switching in Rheumatoid Arthritis Patients
International Journal of Molecular Sciences
2025Article
Predicting Clinical Response to Monoclonal TNF Inhibitors in Rheumatoid Arthritis: A Transcriptomic Approach Based on Transmembrane TNF Reverse Signaling and Nrf2 Activation
Diagnostics
2025Article
Comparative Efficacy and Safety of Anakinra and Canakinumab in Patients With VEXAS Syndrome: An International Multicenter Study
Arthritis & rheumatology
2024Article
Do SMS/e-mail reminders increase influenza vaccination of rheumatoid arthritis patients under anti-TNF: a nested randomized controlled trial in the ART e-cohort
Rheumatology
2022Article
Changes in etanercept and adalimumab biosimilar prescriptions for the initial treatment of rheumatoid arthritis in France: Data from the ART-SFR Registry
Joint Bone Spine
2021Article
Association Between Tumor Necrosis Factor Inhibitors and the Risk of Hospitalization or Death Among Patients With Immune-Mediated Inflammatory Disease and COVID-19
JAMA Network Open
2021Article
Evidence for tmTNF reverse signaling in vivo
iScience
2021Article
Prise en charge des patients atteints de maladies rhumatismales pendant la pandémie de COVID-19 : la Société française de rhumatologie répond aux questions fréquentes posées jusqu’en mai 2020
Revue du Rhumatisme
▶La Consult' SPIN-OFF d'Alain Cantagrel
What's up Doc
▶#08 « Le risque infectieux » par le Pr Alain Cantagrel
Polyarthrite Andar
▶Traitements d'aujourd'hui et de demain (polyarthrite), par le Pr Cantagrel
afa Crohn RCH
▶Rhumatologie : "Les progrès thérapeutiques sont incroyables" - Pr. Cantagrel
esanum France
▶Pr Alain Cantagrel
Uemv Fmsf
Encadrement de doctorants — signal d'activité universitaire.
Données issues de l'Annuaire Santé (ANS) — Licence Ouverte 2.0. Enrichissements à partir de sources publiques. Vous êtes le praticien référencé ? Faites corriger ou retirer votre fiche : demande de rectification ou de retrait.